Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • MORE +
    • Contact Us
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
March 10, 2016 12:00 AM

Does CMS' Part B drug proposal usurp clinical judgment?

Virgil Dickson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Medicare's plans to overhaul the way it reimburses doctors and hospitals for the more than $20 billion worth of outpatient drugs they administer each year has sharply divided the provider community. The fault lines roughly align with the stakes in the status quo.

    The five-year pilot is intended to test the effectiveness of strategies that remove the profit motive from using more expensive drugs over cheaper alternatives.

    Although some physicians would actually end up with higher payments, the plan would deliver a blow to those in a handful of specialties, particularly oncologists, ophthalmologists and rheumatologists, who earn substantial shares of their revenue from Medicare's longstanding method of paying them a drug's average sales price, or ASP, plus 6%.

    “It's basic economics, if you look at oncology practices, the majority of the revenue is coming from drug sales,” said Neeraj Sood, director of research at the Schaeffer Center for Health Policy and Economics at the University of Southern California. “Doctors are human. The fact is, this model changes how much money they'll make.”

    The first change that the Center for Medicare and Medicaid Innovation would test under the pilot would be to pay 2.5%, plus a flat fee of $16.80 (instead of 6%) on top of the ASP. That means reimbursement would go up for lower-priced drugs and down for expensive drugs.

    The CMS estimated in the proposed rule (PDF) that Part B payments to medical oncologists—$1.2 billion in 2014, including the acquisition costs—would decline by 0.7%, compared with a 1.3% increase across all specialties.

    Medicare Part B specialties

    The pharmaceutical industry, oncology groups and Republican lawmakers quickly and harshly criticized the proposal as inappropriately experimenting with patients' medical treatments.

    “This is about the government inserting itself and stating that physicians are not correctly treating patients and that it knows better,” said Ted Okon, executive director of the Community Cancer Alliance. “That's a very slippery slope in terms who is controlling medical care.”

    Anticipating that criticism while announcing the plan, CMS Deputy Administrator Dr. Patrick Conway said “nothing in this proposed payment model will prevent the doctor from prescribing the exact treatment they think their patients needs.”

    Providers in certain geographic areas of the U.S. would continue to get the 6%, however, so the government can measure the effect of the policy on prescribing patterns.

    “The model could ultimately result in seniors' receiving different standards of care based solely on where they live in the country,” House Ways and Means Committee Chairman Kevin Brady (R-Texas), House Energy and Commerce Committee Chairman Fred Upton (R-Mich.), and Senate Finance Committee Chairman Orrin Hatch (R-Utah) said in a joint statement.

    The day after unveiling the proposal and getting blasted with criticism, the CMS sent reporters a list of enthusiastic quotes from clinicians, along with their e-mail addresses.

    The plan, which draws from work by Medicare Payment Advisory Commission, academic studies and models already adopted by private payers, was widely praised by policy experts who have long argued the Part B payment structure delivers perverse incentives.

    “I would argue that there really isn't an argument to keep things as they are now,” said Maura Calsyn, director of health policy at the Center for American Progress, a liberal think tank. “The ASP plus 6% is an incentive to prescribe more specialty drugs, which are more expensive.”

    Family practice physicians, who generally administer cheaper drugs than their peers in oncology, would see their Part B drug payments rise nearly 44%, the CMS estimates—although that revenue represents a much smaller share of their overall revenue.

    Dr. Robert Wergin, a rural family practice physician at the Milford (Neb.) Family Medical Center and chair of the American Academy of Family Physicians, said primary-care providers are more sensitive to their patients' 20% cost-sharing obligations. “This model is about better patient care and less about financial margins,” Wergin said.

    Medicare Part B drug spending

    Hospital groups so far have offered only tentative feedback on the proposal. MedPAC and HHS' Office of Inspector General have pointed out that the growing number of hospitals in the federal 340B drug discount program do well under the current structure because they get the same reimbursement even though their acquisition costs for outpatient drugs are lower.

    “We agree in principle to reducing the cost-sharing burden on patients and promoting evidence-based prescribing,” said Dr. Bruce Siegel, CEO of the trade group America's Essential Hospitals. “But we caution against fundamentally altering current payment practices until we fully understand the impact of these changes on patient access to care.”

    As Medicare has been moving away fee for service to value-based payment models, some experts have found it surprising that the CMS hasn't previously targeted drug spending.

    Under a second phase of the pilot, the CMS intends to test a “menu of value-based purchasing options,” again trying different policies in different regions.

    One idea on that menu is to enter into voluntary agreements with drug manufacturers to link patient outcomes with price adjustments, which would give Medicare some say in determining the prices it pays for drugs.

    “This is major move that may save hundreds of millions,” said Dr. Bill Bithoney, chief physician officer at consulting firm BDO's Center for Healthcare Excellence & Innovation.

    Andrew Ryan, an associate professor of health management and policy at the University of Michigan, said he was especially pleased with inclusion of reference pricing, or setting a benchmark price for a group of therapeutically similar drugs.

    “I think in a lot of ways, drugs have been left behind in the value-based payment initiatives,” Ryan said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    rural-health1.png
    Transgender patients in rural states struggle to find doctors
    The Check Up: John Nickens, LCMC Health
    The Check Up: John Nickens, LCMC Health
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • MORE +
      • Contact Us
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing